NPC's John O'Brien to Speak at Asembia's AXS24 Summit

NPC President and CEO John M. O'Brien, PharmD, MPH will be participating in a panel discussion focused on the future of value-based contracting as part of Asembia's Specialty Pharmacy Summit, April 28 - May 2, 2024 in Las Vegas. 

Payers and Value Based Contracting What is the Future

Tuesday, April 30 | 3:00 PM-3:40 p.m. PT

Government and Commercial Payers are focusing on Pharmaceuticals with respect to their role and participation in Value Based Contracting Agreement Initiatives based on improving performance, outcomes and value. Dr. O'Brien and fellow panelists will speak to the why and how this new era in partnering with Pharma and providers will develop over time.

Moderator: 

• Burt Zweigenhaft, Executive Director & Co-Founder, AVBCC 

Panelists: 

• Emily Colaizy, VP, Pharmaceutical Trade Relations, Prime Therapeutics 
• Ross Hoffman, Former Chief Medical Officer, Centene 
• John O'Brien, President and CEO, National Pharmaceutical Council 
• Kent Rogers, Venture Partner, ARCH Venture Partners 
• Lucy Ruwitch Langer, National Medical Director, Oncology and Genomics, UnitedHealthcare